American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$263M |
| 2 |
Church & Dwight Co
CHD
|
+$176M |
| 3 |
Lattice Semiconductor
LSCC
|
+$159M |
| 4 |
UnitedHealth
UNH
|
+$159M |
| 5 |
Meta Platforms (Facebook)
META
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$314M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$243M |
| 3 |
Air Products & Chemicals
APD
|
+$201M |
| 4 |
HES
Hess
HES
|
+$194M |
| 5 |
Visa
V
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.39% |
| 2 | Financials | 13.48% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRGE
2576
DELISTED
Forge Global Holdings
FRGE
| $254K | ﹤0.01% |
4,936
+1,750
| +55% | +$74.3K |
|
|
CFLT
2577
DELISTED
Confluent
CFLT
| $253K | ﹤0.01% |
10,811
+337
| +3% | +$8.14K |
|
2578
Matrix Service
MTRX
$330M
| $252K | ﹤0.01% |
+25,756
| New | +$280K |
|
2579
Allogene Therapeutics
ALLO
$714M
| $251K | ﹤0.01% |
78,147
+22,611
| +41% | +$64.1K |
|
2580
Rocket Pharmaceuticals
RCKT
$374M
| $251K | ﹤0.01% |
+8,370
| New | +$185K |
|
2581
Tejon Ranch
TRC
$441M
| $246K | ﹤0.01% |
14,303
+1,382
| +11% | +$22.4K |
|
|
TGB
2582
Trekor Metals
TGB
$3.2B
| $246K | ﹤0.01% |
175,202
-25,100
| -13% | -$30.8K |
|
|
SWTX
2583
DELISTED
SpringWorks Therapeutics
SWTX
| $245K | ﹤0.01% |
+6,706
| New | +$175K |
|
|
AMK
2584
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $243K | ﹤0.01% |
8,123
-12
| -0.1% | -$308 |
|
2585
Bank7 Corp
BSVN
$495M
| $243K | ﹤0.01% |
+8,876
| New | +$211K |
|
2586
Organon & Co
OGN
$3.59B
| $241K | ﹤0.01% |
16,693
+266
| +2% | +$3.62K |
|
2587
Atea Pharmaceuticals
AVIR
$405M
| $240K | ﹤0.01% |
78,754
+22,861
| +41% | +$69.2K |
|
2588
QuantumScape Corp
QS
$3.92B
| $240K | ﹤0.01% |
34,473
+2,092
| +6% | +$13.2K |
|
|
CONN
2589
DELISTED
Conn's Inc.
CONN
| $239K | ﹤0.01% |
53,840
-85,134
| -61% | -$281K |
|
2590
Atlanta Braves Holdings Series A
BATRA
$3.63B
| $239K | ﹤0.01% |
5,586
-92
| -2% | -$3.68K |
|
|
TDAY
2591
USA Today Co
TDAY
$1.01B
| $238K | ﹤0.01% |
103,537
+80,522
| +350% | +$179K |
|
2592
Cogent Communications
CCOI
$525M
| $236K | ﹤0.01% |
3,107
-10,738
| -78% | -$717K |
|
2593
Oportun Financial
OPRT
$346M
| $236K | ﹤0.01% |
60,438
-11,968
| -17% | -$51.1K |
|
2594
AnaptysBio
ANAB
$1.69B
| $236K | ﹤0.01% |
11,012
+159
| +1% | +$2.74K |
|
2595
Ichor Holdings
ICHR
$2.59B
| $234K | ﹤0.01% |
6,970
-60
| -0.9% | -$1.66K |
|
2596
F&G Annuities & Life
FG
$3.48B
| $234K | ﹤0.01% |
+5,087
| New | +$190K |
|
|
ZYXI
2597
DELISTED
Zynex
ZYXI
| $232K | ﹤0.01% |
21,303
+4,390
| +26% | +$39.1K |
|
|
OLPX
2598
DELISTED
Olaplex Holdings
OLPX
| $232K | ﹤0.01% |
91,175
+43,727
| +92% | +$86.3K |
|
|
ENFN
2599
DELISTED
Enfusion, Inc.
ENFN
| $229K | ﹤0.01% |
+23,606
| New | +$221K |
|
2600
AngioDynamics
ANGO
$651M
| $228K | ﹤0.01% |
29,102
+9,690
| +50% | +$67.2K |
|
Similar funds
American Century Companies's Q4 2023 Portfolio in Review
As of Q4 2023, American Century Companies held 2,961 positions worth $145B, up 12% from $130B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q4 2023 filing shows 141 new, 1,802 increased, 780 reduced and 86 closed positions. Its largest new stake was Nextpower Inc: 1,286,526 shares worth $60.3M. The largest sale was Humana, an estimated $314M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2023 buy was Nextpower Inc: 1,286,526 shares worth $60.3M.
- American Century Companies added most to Salesforce in Q4 2023, an estimated $263M increase.
- American Century Companies's biggest Q4 2023 reduction was Humana, cutting an estimated $314M.
- American Century Companies fully exited Earthstone Energy Inc. Class A Common Stock in Q4 2023, selling an estimated $58.9M.
- American Century Companies's ten largest holdings make up 23% of its $145B portfolio in Q4 2023.
- American Century Companies opened 141 new positions and closed 86 in Q4 2023.
- American Century Companies's portfolio value rose 12% quarter-over-quarter to $145B.
Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.